Core Viewpoint - Semler Scientific, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding a material investigation by the U.S. Department of Justice related to the False Claims Act [2][4]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as March 10, 2021, to April 15, 2025 [2]. - Allegations include failure to disclose a material investigation by the U.S. Department of Justice and discussing potential violations of the False Claims Act in hypothetical terms [2]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares during the specified class period are encouraged to register for the class action, with a deadline of October 28, 2025, to seek lead plaintiff status [3]. - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [3]. Group 3: Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices [4]. - The firm seeks recovery for investors who suffered losses due to false or misleading statements that led to artificial inflation of the company's stock [4].

Core Viewpoint - A class action lawsuit has been filed against Capricor Therapeutics, Inc. for allegedly providing misleading information regarding its lead drug candidate, deramiocel, during the class period from October 9, 2024, to July 10, 2025 [2][4]. Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals and entities who purchased Capricor securities during the specified class period [2]. - Investors have until September 15, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit [2]. Group 2: Allegations Against Capricor - The complaint alleges that Capricor provided materially misleading information about deramiocel's potential to obtain a Biologics License Application (BLA) from the FDA while concealing adverse facts regarding its safety and efficacy data from the Phase 2 HOPE-2 trial [4]. - On July 11, 2025, Capricor announced it received a Complete Response Letter (CRL) from the FDA, denying the BLA due to insufficient evidence of effectiveness and the need for additional clinical data [5]. Group 3: Stock Price Impact - Following the announcement of the CRL, Capricor's stock price fell from $11.40 per share on July 10, 2025, to $7.64 per share on July 11, 2025, reflecting a significant decline [6].

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR). Shareholders who purchased shares of SMLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/semler-scientific-inc-loss-submission-form/?id=166133&from=3 CLASS PERIOD ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of PubMatic, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions that affected the company's stock value during a specified period [1][3]. Summary by Relevant Sections Class Action Details - The class period for the lawsuit is from February 27, 2025, to August 11, 2025 [3]. - Allegations include that PubMatic failed to disclose a significant shift of clients from a top demand side platform buyer to a new platform, leading to reduced ad spend and revenue [3]. Shareholder Actions - Shareholders are encouraged to register for the class action by October 20, 2025, to potentially be appointed as lead plaintiffs [4]. - Registration allows shareholders to receive updates on the case through portfolio monitoring software [4]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - A class action lawsuit has been filed against Centene Corporation for allegedly misleading investors regarding its revenue outlook and growth projections during the specified class period from December 12, 2024, to June 30, 2025 [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals and entities that purchased Centene securities during the class period [1]. - Investors have until September 8, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit [1]. Group 2: Allegations Against Centene - The complaint alleges that Centene created a false impression of having reliable information about its projected revenue and growth while promoting enrollment rates and low morbidity [3]. - On July 1, 2025, Centene withdrew its 2025 guidance, revealing that its market growth across 22 states was lower than expected, leading to a reduction in guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75 [4]. - Following this announcement, Centene's stock price dropped from $56.65 per share to $44.78 per share, a decline of over 40% [4].

Core Viewpoint - Didi has agreed to pay $740 million to settle a class-action lawsuit initiated by investors, asserting that there was no wrongdoing and that the settlement aims to avoid litigation costs and business disruptions [1] Group 1: Lawsuit Background - The lawsuit originated in July 2021, with investors claiming that Didi may have issued misleading business information [1] - The settlement is contingent upon several conditions, including court approval, and does not constitute an admission of any legal liability regarding the claims made in the lawsuit [1] Group 2: Industry Context - Class-action lawsuits are not uncommon for internet companies, with notable cases involving Alibaba, JD.com, Baidu, Pinduoduo, and New Oriental [1] - Pinduoduo faced a class-action lawsuit just five trading days after its IPO in July 2018, with multiple law firms representing investors in seeking to recover losses [1] - Alibaba has encountered multiple investor class-action lawsuits, paying a total of $759 million in settlements over the years, including $325 million in 2018 and $434 million in 2024 [1]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Fiserv, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's Clover platform and its impact on merchant business [1][3]. Allegations - The complaint alleges that Fiserv forced Payeezy merchants to convert to its Clover platform due to issues with the older Payeezy platform [3]. - Clover's revenue growth was temporarily inflated by these conversions, masking a slowdown in new merchant acquisitions [3]. - A significant number of former Payeezy merchants switched to competitors due to Clover's high pricing and inadequate customer service [3]. - As a result, Clover's GPV growth slowed significantly, and its revenue growth became unsustainable [3]. - Fiserv's positive statements regarding Clover's growth strategies and business prospects were deemed materially false and misleading [3]. Class Action Details - The class period for the lawsuit is from July 24, 2024, to July 22, 2025 [3]. - Shareholders are encouraged to register for the class action by September 22, 2025, to participate in potential recovery [4]. - There is no cost or obligation for shareholders to participate in the case [4]. Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its integration with the Food Safety Division of 3M Company, which misled investors about the progress of the integration [2]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as January 5, 2023, to June 3, 2025 [2]. - Allegations include that the defendants downplayed inefficiencies arising from the integration and assured investors of their commitment to resolving these issues quickly [2]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares of NEOG during the specified timeframe are encouraged to register for the class action by the deadline of September 16, 2025 [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [3]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Fiserv, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its Clover platform and the conversion of Payeezy merchants [1]. Group 1: Allegations Against Fiserv - The complaint alleges that Fiserv forced Payeezy merchants to convert to its Clover platform due to cost issues and problems with the older Payeezy platform [1]. - Clover's revenue growth and gross payment volume (GPV) growth were temporarily inflated by these conversions, masking a slowdown in new merchant business [1]. - A significant number of former Payeezy merchants switched to competing solutions shortly after the conversion due to Clover's high pricing and inadequate customer service [1]. - As a result of losing these merchants, Clover's GPV growth significantly slowed, and its revenue growth became unsustainable [1]. - Fiserv's positive statements during the class period regarding Clover's growth strategies and business prospects were deemed materially false and misleading [1]. Group 2: Class Action Details - The class period for the lawsuit is from July 24, 2024, to July 22, 2025, and shareholders are encouraged to register for participation [2]. - The deadline for shareholders to seek lead plaintiff status is September 22, 2025, with no cost or obligation to participate in the case [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. Group 3: About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Viewpoint - The complaint against Flywire alleges violations of federal securities laws, including overstated revenue growth and understated impacts from permit and visa restrictions, leading to materially false public statements [2]. Financial Performance - On February 25, 2025, Flywire reported a net loss of $15.9 million for the fourth quarter of 2024, missed consensus estimates, lowered its 2025 guidance, and announced a restructuring plan involving a 10% workforce reduction [3]. Market Reaction - Following the financial results announcement, Flywire's stock price dropped by $6.59 per share, or 37.4%, closing at $11.05 per share on February 26, 2025 [3].